Jeff Chiprin - Dec 11, 2024 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role
Chief Commercial Officer
Signature
/s/ Jeff Chiprin
Stock symbol
IRMD
Transactions as of
Dec 11, 2024
Transactions value $
$0
Form type
4
Date filed
12/13/2024, 04:00 PM
Previous filing
Dec 6, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRMD Restricted Stock Units Award $0 +2.99K $0.00 2.99K Dec 11, 2024 Common Stock 2.99K Direct F1, F2
transaction IRMD Performance-based Restricted Stock Units Award $0 +2.99K $0.00 2.99K Dec 11, 2024 Common Stock 2.99K Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
F2 The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan. The RSUs vest in three equal annual installments beginning on December 11, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.
F3 The reporting person received performance-based restricted stock units ("PRSUs") under Iradimed Corporation's 2023 Equity Incentive Plan. PRSUs convert into common stock on a one-for-one basis. The PRSUs vest over a three-year performance period from December 12, 2024 through December 11, 2027 on the Company's total stockholder return compared to the NASDAQ US Small Cap Medical Equipment index.